Acquiring at an Enterprise Value of INR 14.5 billion (approximately US $212 million)
Constellation Alpha Capital Corp., a SPAC focused on the healthcare services sector in India, announced late Thursday evening that it has executed a definitive agreement to acquire Medall Healthcare Private Limited (“Medall”), a leading integrated pathology and radiology company located in India. Constellation Alpha is acquiring Medall at an enterprise value of INR 14.5 billion (approximately US $212 million based on an assumed USD/INR exchange rate of US $1.00 to INR 68.4).
Constellation is expected to be the only India-focused healthcare services company to be publicly listed outside of India.
Full details of the transaction have not yet been filed (only a press release), however, Constellation will host an investor conference call to discuss the transaction on August 3, 2018 at 1:00 p.m. EDT.
- Dial: 1-877-870-4263 toll free in the U.S. or 1-412-317-0790 internationally.
- A replay of the call will be available beginning August 6, 2018 on Constellation’s website at www.ConstellationAlpha.com/ir.
TRANSACTION DETAILS
- Constellation Health Holdings (“Holdco”), a wholly owned Singapore subsidiary of Constellation, will acquire 93% of the outstanding shares of Medall at the closing for approximately US$166 million in cash (based on an assumed USD/INR exchange rate of US$1.00 to INR 68.4).
- The remainder of the outstanding shares of Medall to be acquired on June 30, 2019.
- The transaction will be funded by a combination of cash held in trust by Constellation and new indebtedness.
- Constellation will be renamed Constellation Healthcare Corp. and is anticipated to trade on the NASDAQ Capital Market under the ticker symbol “COHC”.
- The transaction is expected to close in the fourth quarter of 2018.
ADVISORS
- Constellation was advised on the transaction by Cowen and Company and Edelweiss Financial Services Limited
- Medall is advised by Moelis & Co.
- Greenberg Traurig, LLP and Khaitan and Co acted as legal counsel to Constellation
- Luthra & Luthra acted as legal counsel to Medall
At the SPAC of Dawn Although the market has largely recovered from a negative stretch last week, the roller coaster is tilted back downward for Trump Media (NASDAQ:DJT), which slid -8% yesterday to $32.57 – one of its lowest points since closing with Digital World last month. Other SPACs and de-SPACs are having a more...
Remember the metaverse? Many do not. Meta’s (NASDAQ:META) attempted transition to virtually living and working seemed to mark a trend that went up and down quickly, but one SPAC deal has both survived that roller coaster and may rise with a second. Back in December 2022, Newbury Street (NASDAQ:NBST) announced a $1.85 billion combination with...
At the SPAC of Dawn Tucked into the bill that provides $95 billion in funding to American allies passed by the House this weekend is another measure that is likely to have far more impact on at least one pending deal in SPAC world. It would appear that the timing was fortuitous for TikTok rival...
With the passage this weekend of $95 billion in funding for Ukraine, Israel and Taiwan by the House of Representatives, some focus has gone back towards the defense sector, which has generally had a good year as a whole. But, SPACs have not been as active in defense, despite the fact that companies in the...
At the SPAC of Dawn As April’s sleepy month for SPAC news continues, there is only one special meeting on the docket to consider a SPAC deal approval, that being today’s vote on Pegasus Digital Mobility‘s (NYSE:PGSS) combination with equipment manufacturer Schmid. Three more SPACs are facing extension votes this week, including Pyrophyte (NYSE:PHYT), whose...